- Home
- NAAS vs VOR Comparison
NAAS vs VOR Comparison
Compare NAAS & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAAS
- VOR
- Stock Information
- Founded
- NAAS 2019
- VOR 2015
- Country
- NAAS China
- VOR United States
- Employees
- NAAS N/A
- VOR N/A
- Industry
- NAAS Other Specialty Stores
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- NAAS Consumer Discretionary
- VOR Health Care
- Exchange
- NAAS Nasdaq
- VOR Nasdaq
- Market Cap
- NAAS 40.1M
- VOR 47.2M
- IPO Year
- NAAS 2017
- VOR 2021
- Fundamental
- Price
- NAAS $2.91
- VOR $0.86
- Analyst Decision
- NAAS
- VOR Strong Buy
- Analyst Count
- NAAS 0
- VOR 7
- Target Price
- NAAS N/A
- VOR $11.36
- AVG Volume (30 Days)
- NAAS 141.1K
- VOR 614.4K
- Earning Date
- NAAS 11-20-2024
- VOR 11-07-2024
- Dividend Yield
- NAAS N/A
- VOR N/A
- EPS Growth
- NAAS N/A
- VOR N/A
- EPS
- NAAS N/A
- VOR N/A
- Revenue
- NAAS $58,241,066.00
- VOR N/A
- Revenue This Year
- NAAS $19.53
- VOR N/A
- Revenue Next Year
- NAAS $151.36
- VOR N/A
- P/E Ratio
- NAAS N/A
- VOR N/A
- Revenue Growth
- NAAS 199.95
- VOR N/A
- 52 Week Low
- NAAS $1.42
- VOR $0.63
- 52 Week High
- NAAS $59.20
- VOR $3.14
- Technical
- Relative Strength Index (RSI)
- NAAS 45.72
- VOR 53.71
- Support Level
- NAAS $2.50
- VOR $0.75
- Resistance Level
- NAAS $2.95
- VOR $1.06
- Average True Range (ATR)
- NAAS 0.22
- VOR 0.08
- MACD
- NAAS 0.01
- VOR 0.01
- Stochastic Oscillator
- NAAS 56.10
- VOR 42.32
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.